Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Cell & Gene Therapy Debate: Intrinsic Editing vs Systemic Combination

  • Broadcast in Science
Pharma Talk Radio

Pharma Talk Radio

×  

Follow This Show

If you liked this show, you should follow Pharma Talk Radio.
h:548881
s:11869509
archived

In this podcast first recorded at the 2020 IO360° Summit, Dr Aiman Shalabi, GSK, moderated a cell and gene therapy debate on intrinsic editing vs systemic combination 

Participants included:

  • Mark O’Hara, MD, University of Pennsylvania
  • Saul Priceman, PhD, City of Hope

To learn more about the upcoming IO360° 2021 Summit please visit www.io360summit.com

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled